Feedback / Questions
CID-078 - Circle Pharma
https://www.businesswire.com/news/home/20240909646835/en/Circle-Pharma-Announces-Preclinical-Data-Poster-Presentation-of-CID-078-a-First-and-Only-in-Class-Cyclin-AB-RxL-Inhibitor-at-the-2024-World-Conference-on-Lung-Cancer
Sep 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next